164 related articles for article (PubMed ID: 9132594)
1. Valvular heart disease and systemic lupus erythematosus.
Piette JC; Amoura Z; Papo T
N Engl J Med; 1997 May; 336(18):1324; author reply 1324-5. PubMed ID: 9132594
[No Abstract] [Full Text] [Related]
2. Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: an old disease but a persistent challenge.
Ferreira E; Bettencourt PM; Moura LM
Rev Port Cardiol; 2012 Apr; 31(4):295-9. PubMed ID: 22386150
[TBL] [Abstract][Full Text] [Related]
3. Valvular heart disease and systemic lupus erythematosus.
McCarthy GM; McCarty DJ
N Engl J Med; 1997 May; 336(18):1324; author reply 1324-5. PubMed ID: 9132593
[No Abstract] [Full Text] [Related]
4. [Association of antiphospholipid antibodies with valvular heart disease in patients with systemic lupus erythematosus].
Hosaka K; Okada J; Ogiwara A; Kobayashi A; Kondo H
Ryumachi; 1994 Feb; 34(1):22-9. PubMed ID: 8146724
[TBL] [Abstract][Full Text] [Related]
5. Valvular and coronary heart disease in systemic inflammatory diseases: Systemic Disorders in heart disease.
Roldan CA
Heart; 2008 Aug; 94(8):1089-101. PubMed ID: 18625800
[No Abstract] [Full Text] [Related]
6. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease.
Bulckaen HG; Puisieux FL; Bulckaen ED; Di Pompeo C; Bouillanne OM; Watel AA; Fauchais AL; De Groote P; Millaire A
Mayo Clin Proc; 2003 Mar; 78(3):294-8. PubMed ID: 12630582
[TBL] [Abstract][Full Text] [Related]
8. Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.
Meyer O; Golstein M; Nicaise P; Labarre C; Kahn MF
Clin Rev Allergy Immunol; 1995; 13(1):49-56. PubMed ID: 7648348
[No Abstract] [Full Text] [Related]
9. Antiphospholipid syndrome nephropathy in antiphospholipid antibody-positive patients with systemic lupus erythematosus: comment on the article by Tektonidou et al.
Korkmaz C
Arthritis Rheum; 2005 Mar; 52(3):988-9; author reply 989-90. PubMed ID: 15751054
[No Abstract] [Full Text] [Related]
10. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus.
Alarcón-Segovia D; Estañol B; García-Ramos G; Villa AR
Ann N Y Acad Sci; 1997 Aug; 823():279-88. PubMed ID: 9292055
[No Abstract] [Full Text] [Related]
12. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndrome and antiphospholipid antibodies.
Paira SO
J Rheumatol; 1998 Dec; 25(12):2476-7. PubMed ID: 9858454
[No Abstract] [Full Text] [Related]
13. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
Naarendorp M; Spiera H
J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies.
Roldan CA; Shively BK; Lau CC; Gurule FT; Smith EA; Crawford MH
J Am Coll Cardiol; 1992 Nov; 20(5):1127-34. PubMed ID: 1341885
[TBL] [Abstract][Full Text] [Related]
15. Valvular heart disease in systemic lupus erythematosus: another symptom of the disease or a hallmark of secondary antiphospholipid syndrome?
Musial J
Eur Heart J; 1997 Nov; 18(11):1836-7. PubMed ID: 9402462
[No Abstract] [Full Text] [Related]
16. Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.
Tincani A; Rebaioli CB; Taglietti M; Shoenfeld Y
Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv8-13. PubMed ID: 16980725
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of cardiac valves in antiphospholipid syndrome].
Sergakova LM; Fomicheva OA; Vil'chinskaia MI; Alekberova ZS; Aleksandrova EN; Karpov IA; Nasonov EL; At'kov OI
Klin Med (Mosk); 1996; 74(9):39-42. PubMed ID: 9121087
[TBL] [Abstract][Full Text] [Related]
18. [Atypical verrucous endocarditis (Libman-Sacks disease)].
Nakamura H
Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():347-8. PubMed ID: 17953016
[No Abstract] [Full Text] [Related]
19. Arterial thrombosis in systemic lupus erythematosus.
Sabio JM; Jiménez-Alonso J
N Engl J Med; 2004 Oct; 351(18):1910-1; author reply 1910-1. PubMed ID: 15509829
[No Abstract] [Full Text] [Related]
20. [A case of primary antiphospholipid antibody syndrome associated with procainamide induced systemic lupus erythematosus].
Muramatsu M; Nakajima M; Mori M; Sobashima H; Sano H; Katao K
Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1736-8. PubMed ID: 8537731
[No Abstract] [Full Text] [Related]
[Next] [New Search]
